ABEONA THERAPEUTICS INC. Net Assets
ABEONA THERAPEUTICS INC. (ABEO) had Net Assets of $51.40 million as of 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Notes
us-gaap:AssetsNet · last filed 2022-03-31
- 2021-12-31: Net Assets $51.40M.
- 2021-09-30: Net Assets $79.70M.
- 2021-06-30: Net Assets $84.10M.
- 2021-03-31: Net Assets $94.40M.
| Period end | Net Assets |
|---|---|
| 2021-12-31 | $51.40M 10-K · filed 2022-03-31 |
| 2021-09-30 | $79.70M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $84.10M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $94.40M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $102.60M 10-K · filed 2021-03-24 |
| 2020-09-30 | $115.10M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $121.10M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $132.40M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $178.43M 10-K · filed 2020-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |